The current stage of its development is characterized by change of generations in all groups of psychotropic drugs. New medicines have first of all a greater breadth of clinical activities at the selectivity of neurochemical and qualitatively higher tolerance, identified as non-conventional indications for their use, and other, previously unknown positive clinical effects. Much progress has occurred in understanding the biological mechanisms of action of psychotropic drugs, including genetically determined factors that can hope to achieve in the near future, new peaks in the psychopharmacological treatment of mental illness. References: 1. Avrutsky GY, Neduva AA Treatment of the mentally ill. / / Moscow, Medicine, pp. 1988 528. 2. Avrutsky GY Some patterns of drug pathomorphism schizophrenia: Problems of Psychopharmacology, 1976, pp. 517. 3. Avrutsky GY Changing clinics and course of psychosis as a result of mass psychopharmacological and their implications for improving medical care / / J. Neuropathology and Psychiatry. SS Korsakova, 1979, N8, with. 13871394. 4. Zhislin SG On the change in course and symptoms of psychosis in the treatment of modern psychotropic drugs: Problems of Psychopharmacology, M., 1962, pp. 7385. 5. Mosolov SN Chronobiological aspects normotimicheskogo of anticonvulsants and lithium salts. / / Anticonvulsants in psychiatric and neurological practice. / Edited by AM Vein and SN Mosolov, pp. 72253. 6. Mosolov SN Clinical use of modern antidepressants. / / Medical News Agency. SP, 1995, pp. 568. 7. Mosolov SN Fundamentals of pharmacotherapy. / / M., 1996, pp. 288. 8. Mosolov SN Biological Basis of Modern antipsychotic therapy / / Russian Journal of Psychiatry, 1998, N6, s.712. 9. Mosolov SN Psychometric scale assessment of symptoms of schizophrenia and the concept of positive and negative disorders / M., New Color, 2001, 238s. 10. Smulevich AB, Vartanian FE, Zavidovskaya GI Rumyantsev, GM Some problems pamorfoza schizophrenia associated with the use of psychotropic drugs, Vestnik AMN USSR, 1971, N5, s.7985. 11. Smulevich AB, Gindikin VJ, Avedisova AS etc. Application of psychotropic agents in somatic network. / / Journal of Neuropathology and Psychiatry, 1985, (4., Pp. 594 599. 12. Smulevich AB, Panteleyev GP Some actual problems of clinical pharmacotherapy. / / Journal of Neuropathology and Psychiatry., 1983, (9, with. 1345 1351. 13. Tiganov A. Guide to Psychiatry in 2 volumes / Medicine, 1999. 14. Delay J., Deniker P. Methodes chimiotherapeutique en Psychiatrie. / / Paris, Masson, 1961, 496 p. 15. Ginestet D., Kapsambelis V. Therapeutique medicamenteuse des troubbes psychiatriques de L. Adulte. / / Medecine Sciences, Flammarion, Paris, 1996, 402 p. 16. Petrilowitsch N. Psychiatrislhe Krankheitsleitslehre and psychiatrische Pharmakotherapie 2Aufl., Basel, 1968. 17. Shader RI Manual of Psychiatric Therapeutic. / / Little, Brown and Comp. (Inc), 1994, 496 p.
No comments:
Post a Comment